INCIDAL INCIDAL HYDROCIDAL HYDROMIN HISTAL HISTALEX MEBDAL MEBDAL MEBDAL DOLCIDOL NEXIDAL MEBOLIN HISTAROL MEBCIDINA HYDROLATE

Dose: 50 to 100 mg
Single Dose: 75 (75)
Frequency: 8 hourly
Route: PO
Instructions:

Dose: 6.25 mg/kg
Single Dose: 6.2 (6.25)
Frequency: 12 hourly
Route: Oral
Instructions:

Dose: 5 mg/kg
Single Dose: 5 (5)
Frequency: 8 hourly
Route: Oral
Instructions: -

belongs to Methyl Carboline. It belongs to H1-antagonist pharmacological group on the basis of mechanism of action. The Molecular Weight of Mebhydrolin is 276.40. Its pKa is 6.7.

Mebhydrolin is contraindicated in conditions like Prostatic hypertrophy,Narrow-angle glaucoma,Hypersensitivity to any component of product.

The severe or irreversible adverse effects of Mebhydrolin, which give rise to further complications include Granulocytopenia, Neutropenia, Agranulocytosis.Mebhydrolin produces potentially life-threatening effects which include Blood dyscrasias. which are responsible for the discontinuation of Mebhydrolin therapy.The symptomatic adverse reactions produced by Mebhydrolin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Sleepiness, Drowsiness.

Mebhydrolin is primarily indicated in conditions like Allergy, Angioedema, Angiooedema, Eczema, Hay fever, Pruritus, Rhinitis, Urticaria.

No data regarding the interactions of Mebhydrolin was found.

Detection of IgE antibodies for allergy diagnosis

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Patients should observed caution while driving or performing other tasks requiring alertness, because may cause drowsiness. Mebhydrolin should be used with caution in patients with liver impairment, dose should be reduced in patients with renal impairment.